Endocrine Society Applauds Historic Law Adopting Medicare Insulin Price Cap
Society to continue pressing for insulin affordability measures for people with private insurance. The Endocrine Society is elated about President Joe Biden signing into law the Inflation Reduction Act, which includes meaningful measures to make insulin more affordable. The legislation has been a long-term goal of the Society and is a monumental moment in the...
Endocrine Society Celebrates Passage of Historic Insulin Affordability Measure
Society urges House of Representatives to pass and send to President Biden without delay. The Endocrine Society cheered the Senate’s passage of the Inflation Reduction Act, including meaningful measures to make insulin more affordable. The Society urges the House of Representatives to pass this bill and send it to President Biden without delay. The bill’s...
Endocrine Society Hires Haile-Selassie as Chief Financial Officer
Making the GRADE: Endocrine Society Clinical Practice Guidelines Get a Refresh
Endocrine Society Journals Earn Higher Impact Factors for 2021
VIDEO: Endo Cares Reaches Out to Local Community at ENDO 2022 in Atlanta
Endocrine Society members Melanie Haines, MD, and Priya Vellanki, MD, discuss the Endocrine Society’s Endo Cares event that took place during ENDO 2022 in Atlanta with Endocrine News editor, Mark A. Newman. [VIDEO] On Sunday June 12 during ENDO 2022, Endocrine News editor Mark A. Newman spoke with Melanie Haines, MD, and Priya Vellanki, MD,...
The Endocrine Society announces its endorsement of the bipartisan insulin bill introduced by Sens. Jeanne Shaheen (D-NH) and Susan Collins (R-ME) that would take steps to reduce out-of-pocket costs of insulin, the escalating price of insulin, and formulary management for people with diabetes. The INSULIN Act aligns with recommendations in the Society’s Insulin Access and Affordability...